← Open Payments lookup

ABIGAIL CUMMINGS: Open Payments

NPI 1184226201 · LEWISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,579 in 238 payments from 15 companies in 2025. Trend: 2023 $2,998 · 2024 $3,198 · 2025 $3,579

Food & beverage: $3,579
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.33$677
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)56$504
Neurocrine BioSciences, Inc.22$366
Collegium Pharmaceutical, Inc.24$337
ABBVIE INC.25$300
Alkermes, Inc.14$284
E.R. Squibb & Sons, L.L.C.14$210
Lundbeck LLC13$196
Takeda Pharmaceuticals U.S.A., Inc.11$189
Janssen Pharmaceuticals, Inc10$180

Products named: REXULTI, CAPLYTA, INGREZZA, Jornay PM, VRAYLAR, ABILIFY MAINTENA, COBENFY, TRINTELLIX.

Industry payments across PA — which companies pay providers there.